• Home
  • NEW DAY MEDICINE
  • 5 (67) 2024
  • 72 -5 (67) 2024 - Nabieva Zumrat Tokhtaevna - OCCURRENCE AND MODERN DIAGNOSIS OF MYCOPLASMA AND CANDIDA PNEUMONIA IN CHILDREN

72 -5 (67) 2024 - Nabieva Zumrat Tokhtaevna - OCCURRENCE AND MODERN DIAGNOSIS OF MYCOPLASMA AND CANDIDA PNEUMONIA IN CHILDREN

OCCURRENCE AND MODERN DIAGNOSIS OF MYCOPLASMA AND CANDIDA PNEUMONIA IN CHILDREN

Nabieva Zumrat Tokhtaevna - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Mycoplasma pneumonia is a bacterium that can cause disease by damaging the mucous membrane of the respiratory system (throat, lungs, and trachea). People, especially children, can have bacteria in their nose or throat at one time or another without getting sick.

Keywords: pneumonia, mycoplasma, candidiasis, sore throat, infection, bacterium

First page

414

Last page

417

For citation: Nabieva Zumrat Tokhtaevna - OCCURRENCE AND MODERN DIAGNOSIS OF MYCOPLASMA AND CANDIDA PNEUMONIA IN CHILDREN//New Day in Medicine 5(67)2024 414-417 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Steinbach WJ, Fisher BT. International collaborative on contemporary epidemiology and diagnosis of invasive fungal disease in children. J Pediatric Infect Dis Soc. (2017) doi: 10.1093/jpids/pix039
  2. Ahangarkani F, Shokohi T, Rezai MS, Ilkit M, Mahmoodi Nesheli H, Karami H, et al. Epidemiological features of nosocomial candidaemia in neonates, infants and children: a multicentre study in Iran. Mycoses. (2020) 63:382–94.
  3. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. (2007) 20:133–63.
  4. Pana Z.D, Roilides E, Warris A, Groll AH, Zaoutis T. Epidemiology of invasive fungal disease in children. J. Pediatric Infect Dis Soc. (2017) 6:S3–11. doi: 10.1093/jpids/pix046
  5. Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, et al. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents. (2014) 43:78–81. doi: 10.1016/j.ijantimicag.2013.09.005
  6. Jantarabenjakul W, Yodkitudomying C, Chindamporn A, Suchartlikitwong P, Anugulruengkitt S, Pancharoen C, et al. Pediatric and neonatal invasive candidiasis: species distribution and mortality rate in a Thai tertiary care hospital. Pediatr Infect Dis J. (2021) 40:96–102.
  7. Wen XM, Ren N, Xu XH, Huang X. Distribution and drug resistance of pathogens causing nosocomial infections in national nosocomial infection surveillance network. J Chin Hosp Infect Sci. (2002) 16:241–4.
  8. Tukhtaevna N. Z. The Relationship of Tuberculosis and Pneumonia in Children, Clinical Characteristics //international journal of health systems and medical sciences. – 2023; 168-172.
  9. Nabiyeva, Z. . (2023). Clinical manifestations of chronic diseases органов of the digestive system in children. Инновационные исследования в современном мире: теория и практика, 2(15), 27–28. извлечено от https://in-academy.uz/index.php/zdit/article/view/13239
  10. Кароматов Иномжон Джураевич, Набиева Зумрад Тухтаевна Адаптоген - элеутерококк, свободоягодник колючий (обзор литературы) // Биология и интегративная медицина. 2017. №11. URL: https://cyberleninka.ru/article/n/adaptogen-eleuterokokk-svobodoyagodnik-kolyuchiy-obzor-literatury (дата обращения: 19.12.2023).
  11. Oblokulov Abdurashid Rakhimovich Mukhammadieva Musharraf Ibrokhimovna Sanokulova Sitora Avazovna Khadieva Dora Isakovna. (2023).
  12. Clinical and laboratory features of spontaneous bacterial peritonitis in patients with viral liver cirrhosis. Journal of Advanced Zoology, 44(S2), 3744–3750. Retrieved from http://www.jazindia.com/index.php/jaz/article/view/1716
  13. Mukhammadieva M.I. (2022). Modern clinical and biochemical characteristics of liver cirrhosis patients of viral etiology with spontaneous bacterial peritonitis//Texas Journal of Medical Science. – 2022.- P. 86-90
  14. Jalilova A. S. et al. Approaches to Etiotropic Therapy of Covid-19 in Outpatient Patients //international journal of health systems and medical sciences. – 2022. – Т. 1. – №. 1. – С. 41-44.
  15. Aslonova M. R. (2023). IFN-α status in patients with sars-cov-2 and type 2 diabetes. Proceedings of International Conference on Modern Science and Scientific Studies, 2(10), 23–24. Retrieved from https://econferenceseries.com/index.php/icmsss/article/view/2795

    file

    download